Skip to content

Clinical trials

Phase 1 Parkinson Disease trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 1 Country / region: Canada Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20084
20092
20111
20121
20192
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bial - Portela C S.A.5
McGill University Health Centre/Research Institute of the McGill University Health Centre2
GAAD Medical Research Institute Inc.1
HanAll BioPharma Co., Ltd.1
Ionis Pharmaceuticals, Inc.1
Regeneron Pharmaceuticals1
University of Manitoba1
University of Saskatchewan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease13
Cognitive Dysfunction1
Mood Disorders1
Movement Disorders1
Muscle Rigidity1
Nervous System Diseases1
Parasomnias1
Primary Dysautonomias1
Sleep Initiation and Maintenance Disorders1
Tremor1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.